208 related articles for article (PubMed ID: 6677108)
1. [Clinical study of urinary cytology: with special reference to bladder cancer].
Nemoto S; Ishikawa S; Takeshima H; Iizumi T; Uchida K; Yazaki T; Nemoto R; Rinsho K; Kano S
Hinyokika Kiyo; 1983 Dec; 29(12):1611-5. PubMed ID: 6677108
[TBL] [Abstract][Full Text] [Related]
2. [Clinical study on urinary cytology in renal pelvic and ureteral tumors].
Igarashi H; Ohishi Y; Onodera S; Ohnishi T; Yamazaki H; Tomita M; Tashiro K
Hinyokika Kiyo; 1996 Jul; 42(7):493-6. PubMed ID: 8809556
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of urinary nuclear matrix protein 22 as a marker for bladder cancer].
Kurokawa S; Morita T; Muraishi O; Tokue A
Hinyokika Kiyo; 2001 Apr; 47(4):247-50. PubMed ID: 11411098
[TBL] [Abstract][Full Text] [Related]
4. [Value of cytological examination for postoperative bladder cancer].
Kawachi Y
Hinyokika Kiyo; 1983 Nov; 29(11):1469-74. PubMed ID: 6677099
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of urinary NMP22 (nuclear matrix protein 22) bladder chek in the detection of patients with bladder cancer].
Kitsukawa S; Yamamoto Y; Hosoda S; Otsuru N; Matsumoto T; Matsumoto T; Aizawa T; Noda K; Ito T
Hinyokika Kiyo; 2006 Mar; 52(3):167-72. PubMed ID: 16617867
[TBL] [Abstract][Full Text] [Related]
6. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
[TBL] [Abstract][Full Text] [Related]
7. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
Kumar A; Kumar R; Gupta NP
Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of urinary cytology for upper urinary tract disease].
Takeuchi T; Shinoda I; Kuriyama M; Kobayashi S; Nagatani Y; Komeda H; Takahashi Y; Saito A; Chang PK; Kanematsu M
Hinyokika Kiyo; 1986 Feb; 32(2):177-82. PubMed ID: 3728224
[TBL] [Abstract][Full Text] [Related]
9. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of urinary cytology in bladder tumors--analysis of factors related with positivity of urinary cytology].
Tanaka K; Takashi M; Sahashi M; Shimoji T; Miyake K; Koshikawa T; Shiral T; Kawashima K; Nakajima N; Hamajima N
Hinyokika Kiyo; 1990 Jan; 36(1):7-11. PubMed ID: 1689930
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer.
Wiener HG; Vooijs GP; van't Hof-Grootenboer B
Acta Cytol; 1993; 37(2):163-9. PubMed ID: 8465635
[TBL] [Abstract][Full Text] [Related]
12. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
13. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
[TBL] [Abstract][Full Text] [Related]
14. [Quantification of bladder tumor antigen (BTA trak) and its correlation with bladder cancer grade and stage].
Rodríguez Martínez JJ; Escaf Barmadah S; Allende MT; Raigoso P; Martín Benito JL; Pérez García FJ; Fernández Gómez JM
Arch Esp Urol; 2000; 53(1):1-6. PubMed ID: 10730418
[TBL] [Abstract][Full Text] [Related]
15. Genitourinary cytology.
Yazdi HM
Clin Lab Med; 1991 Jun; 11(2):369-401. PubMed ID: 1873964
[TBL] [Abstract][Full Text] [Related]
16. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
[TBL] [Abstract][Full Text] [Related]
17. [The diagnostic value of flow cytometric DNA analysis in bladder cancer--comparison with conventional cytology].
Kawasaki T
Hinyokika Kiyo; 1991 Nov; 37(11):1481-9. PubMed ID: 1767770
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
19. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
[TBL] [Abstract][Full Text] [Related]
20. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
Sadek S; Soloway MS; Hook S; Civantos F
J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]